For all the advances oncology researchers have made in genomics and precision medicine, one of the most basic questions for cancer patients remains one of the least understood.
What should I eat?
Answers range from vague to predictable: Eat healthy, and keep your weight up. But Faeth Therapeutics is betting it can do much better.
This article is exclusive to STAT+ subscribers
Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.
Already have an account? Log in
Already have an account? Log in
To submit a correction request, please visit our Contact Us page.
STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect